The abstract is read at the publisher; the summary is JClub's.
GIGYF2 variants define a novel autism spectrum disorder subtype, with 10 affected individuals from eight families carrying likely gene-disruptive variants and 13 carrying de novo missense variants.
- Why it matters: ASD is heterogeneous, and linking specific genetic subtypes to biological mechanisms is needed to guide targeted therapeutic strategies.
- What they did: The study integrated clinical genetics, large-scale genomic analyses, and conditional knockout mouse models, then tested synaptic and signaling changes and rescue using rapamycin/Torin1 and Nrp2 knockdown.
- The result: In Gigyf2 cKO mice and Gigyf2 KO neurons, Gigyf2 deficiency produced autistic-like behaviors, cognitive and anxiety-like deficits, disrupted synaptic homeostasis, and impaired IGF-1R/mTOR signaling; mTOR inhibition and Nrp2 knockdown rescued synaptic defects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.